Lord Abbett Health Care I (LHCIX)

Fund Assets	8.56M
Expense Ratio	0.78%
Min. Investment	$1,000,000
Turnover	91.00%
Dividend (ttm)	0.08
Dividend Yield	0.33%
Dividend Growth	-24.95%
Payout Frequency	n/a
Ex-Dividend Date	Dec 2, 2025

Previous Close	25.19
YTD Return	10.33%
1-Year Return	30.06%
5-Year Return	24.37%
52-Week Low	19.45
52-Week High	25.31
Beta (5Y)	n/a
Holdings	57
Inception Date	Jul 31, 2019

About LHCIX

Lord Abbett Health Care Fund Class I is a mutual fund that seeks to achieve long-term capital growth by investing primarily in equities of companies operating within the health care sector. The fund’s portfolio features a diverse selection of businesses involved in pharmaceuticals, biotechnology, medical devices, health care services, and related sub-sectors. By concentrating on the health care industry, the fund aims to capitalize on trends such as medical innovation, demographic changes, and advancements in treatment and technology that drive growth within the sector. The fund typically holds around 60 different securities, providing broad exposure across various health care industries. Class I shares are most suitable for institutional investors, requiring a high minimum initial investment, but offer a lower net expense ratio compared to other share classes. The fund distributes dividends monthly and accrues them daily. Lord Abbett Health Care Fund Class I plays a specialized role in the market by offering investors targeted access to health care companies, making it a potential component for portfolios seeking sector-specific growth and diversification opportunities within the broader equity landscape.

• Fund Family: Lord Abbett
• Category: Health
• Performance Rating: Average
• Risk Rating: Average
• Stock Exchange: NASDAQ
• Ticker Symbol: LHCIX
• Share Class: Class I
• Index: MSCI ACWI/Health Care NR Index

Performance

LHCIX had a total return of 30.06% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.70%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
LHCOX	Class F3	0.68%
LHCVX	Class R6	0.68%
LHCFX	Class F	0.78%
LHCTX	Class R5	0.78%

Top 10 Holdings

43.78% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	10.93%
UnitedHealth Group Incorporated	UNH	4.48%
AstraZeneca PLC	AZN	4.46%
Guardant Health, Inc.	GH	4.34%
Natera, Inc.	NTRA	3.67%
Gilead Sciences, Inc.	GILD	3.45%
Johnson & Johnson	JNJ	3.37%
CVS Health Corporation	CVS	3.33%
Novartis AG	NOVN	3.01%
Galderma Group AG	GALD	2.74%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 2, 2025	$0.0824	Dec 2, 2025
Nov 26, 2024	$0.1098	Nov 26, 2024
Nov 22, 2022	$0.0239	Nov 22, 2022
Nov 23, 2021	$1.4724	Nov 23, 2021
Nov 24, 2020	$2.3119	Nov 24, 2020
Nov 21, 2019	$0.0073	Nov 21, 2019

Data Sources: Tiingo, Twelve Data, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Aug 27, 2026

Data Sources Report a data error